ATE192046T1 - Mycobacterium vaccae zur behandlung von lang andauernden autoimmunerkrankungen - Google Patents
Mycobacterium vaccae zur behandlung von lang andauernden autoimmunerkrankungenInfo
- Publication number
- ATE192046T1 ATE192046T1 AT96201912T AT96201912T ATE192046T1 AT E192046 T1 ATE192046 T1 AT E192046T1 AT 96201912 T AT96201912 T AT 96201912T AT 96201912 T AT96201912 T AT 96201912T AT E192046 T1 ATE192046 T1 AT E192046T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- long
- autoimmune diseases
- mycobacterium vaccae
- lasting
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title abstract 3
- 241000187644 Mycobacterium vaccae Species 0.000 title abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 title 1
- 230000005923 long-lasting effect Effects 0.000 title 1
- 230000001404 mediated effect Effects 0.000 abstract 2
- 206010001935 American trypanosomiasis Diseases 0.000 abstract 1
- 208000024699 Chagas disease Diseases 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 230000004957 immunoregulator effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 201000008827 tuberculosis Diseases 0.000 abstract 1
- 208000019553 vascular disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- External Artificial Organs (AREA)
- Soil Working Implements (AREA)
- Storage Of Fruits Or Vegetables (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929203814A GB9203814D0 (en) | 1992-02-21 | 1992-02-21 | Treatment of long term auto-immune conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE192046T1 true ATE192046T1 (de) | 2000-05-15 |
Family
ID=10710862
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93905460T ATE151641T1 (de) | 1992-02-21 | 1993-02-19 | Mycobacterium vaccae zur behandlung von langwierigen autoimmunerkrankungen |
| AT96201912T ATE192046T1 (de) | 1992-02-21 | 1993-02-19 | Mycobacterium vaccae zur behandlung von lang andauernden autoimmunerkrankungen |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93905460T ATE151641T1 (de) | 1992-02-21 | 1993-02-19 | Mycobacterium vaccae zur behandlung von langwierigen autoimmunerkrankungen |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5885588A (de) |
| EP (2) | EP0630259B1 (de) |
| JP (1) | JPH07506093A (de) |
| KR (1) | KR100275862B1 (de) |
| AT (2) | ATE151641T1 (de) |
| AU (2) | AU675421B2 (de) |
| BG (1) | BG99054A (de) |
| BR (1) | BR9305946A (de) |
| CA (1) | CA2130117A1 (de) |
| CZ (1) | CZ282651B6 (de) |
| DE (2) | DE69328503T2 (de) |
| DK (2) | DK0763361T3 (de) |
| ES (2) | ES2104131T3 (de) |
| FI (1) | FI943849A0 (de) |
| GB (1) | GB9203814D0 (de) |
| GR (2) | GR3024113T3 (de) |
| HU (1) | HU218347B (de) |
| NO (1) | NO311169B1 (de) |
| NZ (1) | NZ249518A (de) |
| RO (1) | RO117833B1 (de) |
| RU (1) | RU2124367C1 (de) |
| SK (1) | SK99994A3 (de) |
| UA (1) | UA35583C2 (de) |
| WO (1) | WO1993016727A1 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9406301D0 (en) * | 1994-03-30 | 1994-05-25 | Univ London | Immunotherapeutic agent and its use |
| IL110011A (en) * | 1994-06-13 | 2004-09-27 | Yeda Res & Dev | Pharmacological preparations for the treatment of schizophrenia |
| GB9505658D0 (en) * | 1995-03-21 | 1995-05-10 | Univ London | Hormone and growth factor mimetics |
| US6056964A (en) * | 1995-03-29 | 2000-05-02 | Stanford Rook Limited | Immunotherapeutic agent and its use |
| US6160093A (en) * | 1996-08-29 | 2000-12-12 | Genesis Researth And Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
| US6284255B1 (en) * | 1996-08-29 | 2001-09-04 | Genesis Research & Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
| AU741016B2 (en) * | 1996-08-29 | 2001-11-22 | Genesis Research And Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
| US5985287A (en) * | 1996-08-29 | 1999-11-16 | Genesis Research And Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
| US6406704B1 (en) | 1996-08-29 | 2002-06-18 | Genesis Research And Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
| US6878377B2 (en) | 1996-12-18 | 2005-04-12 | Stanford Rook Limited | Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system |
| KR100533818B1 (ko) * | 1996-12-18 | 2005-12-07 | 스탠포드 룩 리미티드 | 면역계의 ｔｈ2 활성의 하향 조절을 위한 마이코박테리움 박케 |
| RU2137137C1 (ru) * | 1997-12-03 | 1999-09-10 | Научно-исследовательский институт по изучению лепры | Способ определения m.leprae у больных с регрессом заболевания |
| US5968524A (en) * | 1997-12-23 | 1999-10-19 | Genesis Research & Development Corp. | Methods and compounds for the treatment of immunologically-mediated psoriasis |
| IL136821A0 (en) * | 1997-12-23 | 2001-06-14 | Genesis Res & Dev Corp Ltd | Compositions derived from mycobacterium vaccae and methods for their use |
| US6328978B1 (en) | 1997-12-23 | 2001-12-11 | Genesis Research & Development Corp. Ltd. | Methods for the treatment of immunologically-mediated skin disorders |
| US6350457B1 (en) | 1999-06-02 | 2002-02-26 | Genesis Research & Development Corporation Limited | Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
| WO2001010221A1 (en) * | 1999-08-06 | 2001-02-15 | Corixa Corporation | Vaccines for the treatment of autoimmune disease |
| GB0010496D0 (en) * | 2000-04-28 | 2000-06-14 | Stanford Rook Ltd | Treatment of conditions of the central nervous system |
| GB0106986D0 (en) * | 2001-03-20 | 2001-05-09 | Stanford Rook Ltd | Immunotherapeutic agent |
| GB0106985D0 (en) * | 2001-03-20 | 2001-05-09 | Stanford Rook Ltd | Immunotherapeutic agent |
| JP4875494B2 (ja) | 2003-11-14 | 2012-02-15 | ユーシーエル バイオメディカ ピーエルシー | 免疫調節物質 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8404280D0 (en) * | 1984-02-17 | 1984-03-21 | Stanford J L | Biological preparations |
| IL71683A0 (en) * | 1984-04-27 | 1984-09-30 | Yeda Res & Dev | Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria |
| GB8919321D0 (en) * | 1989-08-25 | 1989-10-11 | Univ London | Treatment of chronic inflammatory conditions |
| CA2095855C (en) * | 1990-11-08 | 2003-04-29 | Graham A.W. Rook | Mycobacterium as adjuvant for antigens |
-
1992
- 1992-02-21 GB GB929203814A patent/GB9203814D0/en active Pending
-
1993
- 1993-02-19 JP JP5514636A patent/JPH07506093A/ja not_active Ceased
- 1993-02-19 NZ NZ249518A patent/NZ249518A/en unknown
- 1993-02-19 RO RO94-01401A patent/RO117833B1/ro unknown
- 1993-02-19 AT AT93905460T patent/ATE151641T1/de not_active IP Right Cessation
- 1993-02-19 DK DK96201912T patent/DK0763361T3/da active
- 1993-02-19 AU AU36377/93A patent/AU675421B2/en not_active Ceased
- 1993-02-19 ES ES93905460T patent/ES2104131T3/es not_active Expired - Lifetime
- 1993-02-19 KR KR1019940702920A patent/KR100275862B1/ko not_active Expired - Fee Related
- 1993-02-19 HU HU9402422A patent/HU218347B/hu not_active IP Right Cessation
- 1993-02-19 ES ES96201912T patent/ES2145968T3/es not_active Expired - Lifetime
- 1993-02-19 RU RU94045825A patent/RU2124367C1/ru not_active IP Right Cessation
- 1993-02-19 CZ CZ942023A patent/CZ282651B6/cs not_active IP Right Cessation
- 1993-02-19 DK DK93905460.7T patent/DK0630259T3/da active
- 1993-02-19 DE DE69328503T patent/DE69328503T2/de not_active Expired - Fee Related
- 1993-02-19 DE DE69309915T patent/DE69309915T2/de not_active Expired - Fee Related
- 1993-02-19 EP EP93905460A patent/EP0630259B1/de not_active Expired - Lifetime
- 1993-02-19 UA UA94095856A patent/UA35583C2/uk unknown
- 1993-02-19 US US08/290,813 patent/US5885588A/en not_active Expired - Fee Related
- 1993-02-19 EP EP96201912A patent/EP0763361B1/de not_active Expired - Lifetime
- 1993-02-19 SK SK999-94A patent/SK99994A3/sk unknown
- 1993-02-19 AT AT96201912T patent/ATE192046T1/de not_active IP Right Cessation
- 1993-02-19 BR BR9305946A patent/BR9305946A/pt not_active Application Discontinuation
- 1993-02-19 WO PCT/GB1993/000351 patent/WO1993016727A1/en not_active Ceased
- 1993-02-19 CA CA002130117A patent/CA2130117A1/en not_active Abandoned
-
1994
- 1994-08-22 FI FI943849A patent/FI943849A0/fi not_active Application Discontinuation
- 1994-08-22 NO NO19943082A patent/NO311169B1/no not_active IP Right Cessation
- 1994-09-21 BG BG99054A patent/BG99054A/xx unknown
-
1996
- 1996-11-20 AU AU71887/96A patent/AU706122B2/en not_active Ceased
-
1997
- 1997-07-16 GR GR970401763T patent/GR3024113T3/el unknown
-
2000
- 2000-06-23 GR GR20000401468T patent/GR3033772T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE192046T1 (de) | Mycobacterium vaccae zur behandlung von lang andauernden autoimmunerkrankungen | |
| ATE132755T1 (de) | Mycobacterium vaccae in der behandlung von uveitis | |
| ATE234921T1 (de) | Osteoinduktive zusammensetzungen | |
| DE69128932D1 (de) | Verfahren zur Herstellung von Epsilon-caprolactam und Aktivierung von festen Katalysatoren dafür | |
| NO920331D0 (no) | Biologisk preparat samt bruk derav | |
| ATE148628T1 (de) | 5-methylisoxazol-4-carbonsäure-anilide und 2- hydroxyethyliden-cyanoessigsäure-anilide zur behandlung von augenkrankheiten | |
| EP0303681A4 (de) | Immunosuppression bei der auf immunotoxin basierten behandlung von menschen. | |
| ATE143804T1 (de) | Zusammensetzung zur behandlung von mastitis und metritis | |
| EP0674905A3 (de) | Bacterin zur Behandlung von Necrophorum-Krankheiten und Verfahren zur Herstellung. | |
| FI901371A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten halogeeni-3,4-dihydro-bentsotiopyranyyliamiinien valmistamiseksi | |
| ATE315583T1 (de) | Analoge des thymosin alpha 1 | |
| DE69128095D1 (de) | Azelluläre impfstoffe | |
| DE68914886D1 (de) | Mittel zur Behandlung von Raynaud's Krankheit. | |
| ATE56874T1 (de) | Zubereitung zur behandlung und vorbeugung von diarrhoee bei menschen und tieren und verfahren zu deren herstellung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |